Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Alphapharm Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (849)
Cancellation by sponsor (780)
Prescription medicine registration (54)
Cancellation or suspension (44)
Australian Public Assessment Report (AusPAR) (3)
Designation or determination (3)
Prescription medicine decision summary (2)
Section 14, TGO91 consent (1)

Date

2024 (18)
2023 (84)
2022 (230)
2021 (265)
2020 (113)
2019 (35)
2018 (66)
2017 (364)
2016 (34)
2015 (22)
2014 (48)
2013 (40)
2012 (61)
2011 (28)
2010 (46)
2009 (25)
2008 (10)
2007 (28)
2006 (6)
2005 (17)
2004 (15)
2003 (33)
2002 (15)
2001 (4)
2000 (14)
1999 (9)
1998 (8)
1997 (11)
1996 (10)
1995 (7)
1994 (6)
1993 (12)
1992 (11)
1991 (41)

Results for "[search-keyword]"

Search

Sponsor content

1736 result(s) found, displaying 581 to 590

Diclofenac Sodium Delayed-release Tablets USP 50 mg Cancelled under Section 30(1)(c) of the Act

19 March 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
VERAPAMIL 40 mg tablet bulk (AF) Cancelled under Section 30(1)(c) of the Act

19 March 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
ALPHAPHARM SELEGILINE HYDROCHLORIDE 5mg (AF2) tablet bulk Cancelled under Section 30(1)(c) of the Act

19 March 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
ALPHAPHARM BEZAFIBRATE 200mg tablet bulk Cancelled under Section 30(1)(c) of the Act

19 March 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
ALPHAPHARM SELGILINE HYDROCHLORIDE 5mgMG (AF3) tablet bulk Cancelled under Section 30(1)(c) of the Act

19 March 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
ALPHAPHARM SELEGILINE HYDROCHLORIDE 10mg tablet (AP3) bulk Cancelled under Section 30(1)(c) of the Act

19 March 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
FLUOXETINE 10mg (as hydrochloride) tablet bulk (AF) Cancelled under Section 30(1)(c) of the Act

19 March 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
FLUOXETINE 20mg TABLETS bulk (AF) Cancelled under Section 30(1)(c) of the Act

19 March 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
DANAZOL CAPSULES 100mg (AF1) bulk Cancelled under Section 30(1)(c) of the Act

19 March 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
DANAZOL CAPSULES 200mg (AF2) bulk Cancelled under Section 30(1)(c) of the Act

19 March 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd

Pages

First page
Previous page
…
Page 55
Page 56
Page 57
Page 58
Current page 59
Page 60
Page 61
Page 62
Page 63
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.